Medical marijuana users in substance abuse treatment

Harm Reduction Journal

Volumn 7, Issue , 2010, Pages

  Swartz, Ronald ^a  

^a HUMBOLDT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; METHAMPHETAMINE;

ADULT; ALCOHOL ABUSE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; CRIMINAL JUSTICE; DRUG DEPENDENCE TREATMENT; DRUG USE; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; METHODOLOGY; PATIENT ATTITUDE; SOCIAL BEHAVIOR; SUBSTANCE ABUSE; TREATMENT OUTCOME; UNITED STATES; VISUAL DISORDER; WALKING DIFFICULTY;

EID: 79960120307     PISSN: None     EISSN: 14777517     Source Type: Journal    
DOI: 10.1186/1477-7517-7-3     Document Type: Article

References (34)

1. Brook DW, Brook JS, Zhang C, Cohen P, Whiteman M. Drug use and the risk of major depressive disorder, alcohol dependence, and substance use disorders. Archives of General Psychiatry 2002, 59:1039-1044. 10.1001/archpsyc.59.11.1039, 12418937.
2. Fergusson DM, Horwood LJ, Ridder E. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005, 100:354-366. 10.1111/j.1360-0443.2005.01001.x, 15733249.
3. Hall W, Pacula R. Cannabis Use and Dependence. Public Health and Public Policy 2003, Cambridge: Cambridge University Press.
4. Macleod J, Oakes R, Copello A, Crome I, Egger M, Hickman M, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004, 363:1579-88. 10.1016/S0140-6736(04)16200-4, 15145631.
5. Moore T, Zammit S, Lingford-Hughes A, Barnes T, Jones P, Burke M, Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: a systemic review. The Lancet 2007, 370:319-328.
6. Solowij N. Long-term effects of cannabis on the central nervous system. The Health Effects of Cannabis 1999, 195-265. Toronto: Centre for Addiction and Mental Health, Kalant H, Corrigall W, Hall W, Smart R.
7. Joy JE, Watson SJ, Benson JA. Marijuana and Medicine: Assessing the Science Base 1999, National Academy of Sciences, Institute of Medicine. Washington, D.C.
8. American College of Physicians Supporting Research into the Therapeutic Role of Marijuana 2008, Philadelphia, PA, American College of Physicians.
9. Ashton CH, Moore PB, Gallagher P, Young AH. Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. Journal of Psychopharmacology 2005, 19:293-300. 10.1177/0269881105051541, 15888515.
10. Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nature Reviews Drug Discovery 2004, 9:771-784.
11. Müller-Vahl KR. Cannabinoids reduce symptoms of Tourette's syndrome. Expert Opinion on Pharmacotherapy 2003, 4:1717-1725. 10.1517/14656566.4.10.1717, 14521482.
12. Zuardi AW, Crippa JA, Hallak JE, Moreira FA, Guimarães FS. Cannabidiol, a cannabis sativa constituent, as an antipsychotic drug. Brazilian Journal of Medical and Biological Research 2005, 4:421-429.
13. Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, et al. A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain. The Journal of Pain 2008, 9:506-521. 10.1016/j.jpain.2007.12.010, 18403272.
14. Macleod J. Cannabis use and psychosis: the origins and implications of an association. Advances in Psychiatric Treatment 2007, 13:400-411.
15. Hall W, Room R. The Effects of Cannabis Use on Mental Health in a Public Health Perspective 2008, The Beckley Foundation. Oxford, UK.
16. Dyck E. "Hitting Highs at Rock Bottom": LSD Treatment for Alcoholism, 1950-1970. Social History of Medicine 2006, 19:313-329.
17. Sershen H, Hashim A, Harsing L, Lajtha A. Ibogaine antagonizes cocaine-induced locomotor stimulation in mice. Life Sciences 1992, 50:1079-1086. 10.1016/0024-3205(92)90344-O, 1556903.
18. Multidisciplinary Association for Psychedelic Studies. MDMA Research Information. Accessed on November 1, 2008 from., http://www.maps.org/mdma
19. Reiman A. Medical Cannabis Patients: Patient Profiles and Health Care Utilization Patterns. Complementary Health Practice Review 2007, 12:31-50.
20. Nutt D, King L, Saulsbury W, Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. The Lancet 2007, 369:1047-1053.
21. Newman R. "Maintenance" treatment of addiction: To whose credit, and why it matters. International Journal of Drug Policy 2009, 20:1-3. 10.1016/j.drugpo.2008.07.001, 18775657.
22. Brown EG. Guidelines for the Security and Non-Diversion of Marijuana Grown for Medical Use 2008, Sacramento, CA: Department of Justice.
23. Hser YI, Evans E, Huang D, Anglin DM. Relationship Between Drug Treatment Services, Retention, and Outcomes. Psychiatric Services 2004, 55:767-774. 10.1176/appi.ps.55.7.767, 15232015.
24. Office of National Drug Control Strategy National Drug Control Strategy. 2008 Annual Report 2008, Washington, D.C. Executive Office of the President, Office of National Drug Control Strategy.
25. Hardwick S, King L. Home Office Cannabis Potency Study 2008 2008, Home Office Scientific Development Branch, United Kingdom.
26. McLaren J, Swift W, Dillon P, Allsop S. Cannabis potency and contamination: a review of the literature. Addiction 2008, 103:1100-1109. 10.1111/j.1360-0443.2008.02230.x, 18494838.
27. Smith N. High potency cannabis: the forgotten variable. Addiction 2005, 100:1558-60.
28. Harris D, Jones RT, Shank R, Nath R, Fernandez E, Goldstein K, et al. Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases 2000, 19:89-103. 10.1300/J069v19n03_07, 11076122.
29. Swift W, Gates P, Dillon P. Survey of Australians using cannabis for medical purposes. Harm Reduction Journal 2005, 2:18-27. 10.1186/1477-7517-2-18, 1262744, 16202145.
30. Rosen SM, Miller R, Simon M. The Cost of Alcohol in California. Alcoholism: Clinical and Experimental Research 2008, 32:1925-1936.
31. Substance Abuse and Mental Health Services Administration. Summary Report CARAVAN® Survey for SAMHSA on Addictions and Recovery 2008, Rockville, MD: Office of Communications.
32. Leshner A. Addiction is a brain disease, and it matters. Science 1997, 278:45-47. 10.1126/science.278.5335.45, 9311924.
33. Little Hoover Commission For Our Health and Safety: Joining Forces to Defeat Addiction 2003, Sacramento, CA: Little Hoover Commission, Little Hoover Commission.
34. Little Hoover Commission Addressing Addiction: Improving & Integrating California's Substance Abuse Treatment System 2008, Sacramento, CA: Little Hoover Commission, Little Hoover Commission.